Interleukin-2 and Interferon in Treating Patients With Metastatic Kidney Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

Not specified

Study Completion Date

February 28, 2006

Conditions
Kidney Cancer
Interventions
BIOLOGICAL

aldesleukin

BIOLOGICAL

recombinant interferon alfa

All Listed Sponsors
lead

Centre Leon Berard

OTHER

NCT00416871 - Interleukin-2 and Interferon in Treating Patients With Metastatic Kidney Cancer | Biotech Hunter | Biotech Hunter